GGrantIndex
Sort

82,697 grants matching vaccine development

Inflammatory Triggers in B Cell Autoimmunity

$772,437
Garnett H Kelsoe · Duke University · U19 · FY2011 · AI

University of Rochester Center for AIDS Research

$772,427
Stephen Dewhurst · University Of Rochester · P30 · FY2018 · AI

Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB

$772,420
Jennifer A Philips · Washington University · R01 · FY2025 · AI

Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB

$772,420
Jennifer A Philips · Washington University · R01 · FY2024 · AI

TB Vaccine Development in Nonhuman Primate Model

$772,391
John L Vandeberg · Texas Biomedical Research Institute · R01 · FY2006 · AI

Treating flaviviruses with mRNA-encoded Cas13

$772,375
Philip J Santangelo · Emory University · R01 · FY2025 · AI

Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2

$772,370
Robert Virgil Stahelin · Purdue University · R01 · FY2022 · AI

Physiological and therapeutic effects of ANGPTL3 variants in mice and humans

$772,302
Marina Cuchel · University Of Pennsylvania · R01 · FY2021 · HL

Role of the microbiome in HIV vaccine induced heterogeneity

$772,302
James G. Kublin · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AI

ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD

$772,291
Stanford University · P01 · FY2001 · AI

Predicting Post-Covid Pulmonary Fibrosis with Explainable Deep Learning and Optimal Biomarker Discovery

$772,290
Ulas Bagci · Northwestern University At Chicago · R01 · FY2024 · HL

Modeling Filovirus Infection of and Trafficking through Skin

$772,250
Wendy Jean Maury · University Of Iowa · R01 · FY2018 · AI

IGF::OT::IGF PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS

$772,238
Antu Dey · International Aids Vaccine Initiative · N01 · FY2016 · AI

Linking the behavior of individual host cells to their transcriptional signatures

$772,200
Lalita Ramakrishnan · University Of Washington · DP1 · FY2014 · MH

A revolutionary vaccine approach to prevent HIV infection in substance abuse

$772,200
Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2016 · DA

Linking the behavior of individual host cells to their transcriptional signatures

$772,200
Lalita Ramakrishnan · University Of Washington · DP1 · FY2012 · MH

Linking the behavior of individual host cells to their transcriptional signatures

$772,200
Lalita Ramakrishnan · University Of Washington · DP1 · FY2011 · OD

Developmental Projects

$772,196
Dennis L. Kasper · Harvard Medical School · U54 · FY2011 · AI

HIV-1 membrane fusion and inhibition

$772,175
Bing Chen · Boston Children'S Hospital · R01 · FY2024 · AI

Antibody mediated protective immunity against cholera

$772,046
Jason B Harris · Massachusetts General Hospital · R01 · FY2019 · AI

Preclinical development of a chimeric tetravalent dengue vaccine

$771,968
Dan Thomas Stinchcomb · Inviragen, Inc. · U01 · FY2008 · AI

METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES

$771,951
Herbert W Virgin · Washington University · R01 · FY2012 · OD

Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion

$771,898
Frances Eun-Hyung Lee · Emory University · R01 · FY2024 · AI

Project 4: PK-PD of a Combination Antiretroviral Intravaginal Ring in Women

$771,888
Kathleen Listiak Vincent · Oak Crest Institute Of Science · U19 · FY2015 · AI

Attenuating Inflammation to Restore GI Tract Integrity and Reduce Viral Reservoirs During cART

$771,835
Jacob D Estes · Oregon Health & Science University · R01 · FY2021 · DK